Post hoc analysis of 2,241 patients with ACS in FAVOR III China: low residual global μQFR (≤2.71) after PCI was associated with higher 3-year MACE (21.2% vs 10.4%; adjusted HR 1.53) vs higher values.
Secondary analysisn = 2,241
Shen et al. Post-PCI Global QFR and Long-Term Outcomes in ACS: Findings From the FAVOR III China Trial